NewDays raises $16M seed round led by Madrona and General Catalyst, expands AI-driven dementia care to Nevada

Seattle startup NewDays closed a $16 million seed round led by Madrona and General Catalyst to scale a telehealth program combining clinicians with an AI companion, Sunny, for treating mild dementia; early research suggests the platform may preserve about 18 months of cognitive function and the service now operates in six states including Nevada.

No comments yet.